Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm
Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm
About this item
Full title
Author / Creator
Publisher
Iran: Shiraz Institute for Cancer Research
Journal title
Language
English
Formats
Publication information
Publisher
Iran: Shiraz Institute for Cancer Research
Subjects
More information
Scope and Contents
Contents
Vaccines are the most effective way to prevent Coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2).
To compare the antibody response of healthy individuals vaccinated with either the AstraZeneca (ChAdOx1 nCoV-19) or the Sinopharm (BBIBP-CorV) vaccine, in those who had no prior infection with SARS-CoV-2.
Thirty seven participants were...
Alternative Titles
Full title
Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1669f2560b924131b38baf3a2bddcc82
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1669f2560b924131b38baf3a2bddcc82
Other Identifiers
ISSN
1735-1383
E-ISSN
1735-367X
DOI
10.22034/iji.2022.94298.2300
